Fox Run Management’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-16,503
Closed -$112K 1095
2024
Q2
$112K Buy
+16,503
New +$112K 0.02% 715